United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 1,920 United Therapeutics Corporation shares (Form 4)

Traded Sep 30, 2026 · Filed Oct 1, 2026

On Sep 30, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 1,920 United Therapeutics Corporation shares at an average US$550.22 for US$1.06M under a trading plan, leaving 324,443 shares. Filed Oct 1, 2026 (Form 4).

Sold
1,920 shares
Price
US$550.22 average (US$547.29 to US$554.70)
Value
US$1.06M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 30, 2026Common StockSale400US$547.29325,963Indirect
Sep 30, 2026Common StockSale280US$548.25325,683Indirect
Sep 30, 2026Common StockSale240US$549.40325,443Indirect
Sep 30, 2026Common StockSale400US$550.47325,043Indirect
Sep 30, 2026Common StockSale160US$551.50324,883Indirect
Sep 30, 2026Common StockSale120US$552.63324,763Indirect
Sep 30, 2026Common StockSale113US$553.78324,650Indirect
Sep 30, 2026Common StockSale207US$554.70324,443Indirect

Source

View original at SEC

Related